Levetiracetam Monotherapy in Newly Diagnosed Cryptogenic West Syndrome

Pediatric Neurology

Volumn 37, Issue 5, 2007, Pages 350-353

  Gümüş, Hakan ^a   Kumandaş, Sefer ^a   Per, Hüseyin ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ETIRACETAM;

ANTICONVULSANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; MALE; NASOGASTRIC TUBE; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RELAPSE; SEIZURE; WEST SYNDROME;

ANTICONVULSANTS; FEMALE; HUMANS; INFANT; MALE; PIRACETAM; RETROSPECTIVE STUDIES; SPASMS, INFANTILE; TREATMENT OUTCOME;

EID: 35348847340     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.06.019     Document Type: Article

References (29)

1. West W.J. On a peculiar form of infantile convulsions. Lancet 1 (1841) 724-725
2. Commission on the Classification and Terminology of the International League Against Epilepsy. Proposal for the revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
3. Carmant L. Infantile spasms: West syndrome. Arch Neurol 59 (2002) 317-318
4. Fukuyama Y. History of clinical identification of West syndrome-inquest after the classic. Brain Dev 23 (2001) 779-787
5. Hrachovy R.A. West's syndrome (infantile spasms): clinical description and diagnosis. Adv Exp Med Biol 497 (2002) 33-50
6. Trevathan E., Murphy C.C., and Yeargin-Allsopp M. The descriptive epidemiology of infantile spasms among Atlanta children. Epilepsia 40 (1999) 748-751
7. Luthvigsson P., Olafsson E., Sigurthardottir S., and Hauser W.A. Epidemiologic features of infantile spasms in Iceland. Epilepsia 35 (1994) 802-805
8. Van den Berg B.J., and Yerushalmy J. Studies on convulsive disorders in young children. V. Excess of early fetal deaths among pregnancies preceding the birth of children with febrile or nonfebrile convulsions. J Pediatr 84 (1974) 837-840
9. Gates M.J. Age: risk of seizures in infants. In: Alter M., and Hauser W.A. (Eds). The epidemiology of epilepsy: a workshop. NINDS monograph 14 (1972), U.S. Government Printing Office, Washington, DC 123-128
10. Lux A.L., and Osborne J.P. The influence of etiology upon ictal semiology, treatment decisions and long-term outcomes in infantile spasms and West syndrome. Epilepsy Res 70 (2006) 77-86
11. Kivity S., Lerman P., Ariel R., Danziger Y., Mimouni M., and Shinnar S. Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone. Epilepsia 45 (2004) 255-262
12. Lagae L., Buyse G., Deconinck A., and Ceulelmans B. Effect of levetiracetam in refractory childhood epilepsy syndromes. Eur J Paediatr Neurol 7 (2003) 123-128
13. Snead III O.C. Treatment of infantile spasms. Pediatr Neurol 6 (1990) 147-150
14. Watanabe K. Medical treatment of West syndrome in Japan. J Child Neurol 10 (1995) 143-147
15. Dreifuss F.E., Santilli N., Langer D.H., Sweeney K.P., Moline K.A., and Menander K.B. Valproic acid hepatic fatalities: a retrospective review. Neurology 37 (1987) 379-385
16. Patsalos P.N., and Sander J.W.A.S. Newer antiepileptic drugs-towards an improved risk-benefit ratio. Drug Saf 11 (1994) 37-47
17. Appleton R.E. Vigabatrin in the management of generalized seizures in children. Seizure 4 (1995) 45-48
18. Veggiotti P., Cieuta C., Rey E., and Dulac O. Lamotrigine in infantile spasms. Lancet 344 (1994) 1375-1376
19. Hurst D.L., and Rolan T.D. The use of felbamate to treat infantile spasms. J Child Neurol 10 (1995) 134-136
20. Crest C., Dupont S., Leguern E., Adam C., and Baulac M. Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients. Neurology 62 (2004) 640-643
21. French J. Use of levetiracetam in special populations. Epilepsia 42 (2001) 40-43
22. Kossoff E.H., Boatman D., and Freeman J.M. Landau-Kleffner syndrome responsive to levetiracetam. Epilepsy Behav 4 (2003) 571-575
23. Hirsch E., Thibault-Menard A., Valenti M.P., and Chassagnon S. Open study on the efficacy of levetiracetam monotherapy in idiopathic generalized epilepsies. Epilepsia 43 (2002) S187
24. De Los Reyes E.C., Sharp G.B., Williams J.P., and Hale S.E. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 30 (2004) 254-256
25. Lawlor K.M., and Devlin A.M. Levetiracetam in the treatment of infantile spasms. Eur J Paediatr Neurol 9 (2005) 19-22
26. Rossetti A.O., and Bromfield E.B. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 8 (2006) 651-654
27. Frost M.D., Gustafson M.O., and Ritter F.J. Use of levetiracetam (LEV) in children younger than 2 years. Epilepsia 43 (2002) S57
28. Opp J., Tuxhorn I., May T., et al. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany. Seizure 14 (2005) 476-484
29. Buyse G., Ceulamans B., and Lagac L. Add-on levetiracetam in refractory generalized childhood epilepsy syndromes. Epilepsia 43 (2002) S154